Chronic Lung Allograft Dysfunction (CLAD) remains a problem following lung transplantation without definitive treatment except redo lung transplantation (re-LTx) in preferred candidates. were analyzed and collected. A complete of 143 sufferers underwent re-LTx for CLAD leading to 94 BOS (66%) and 49 rCLAD (34%) individuals. Unadjusted and modified survival after re-LTx for rCLAD was worse… Continue reading Chronic Lung Allograft Dysfunction (CLAD) remains a problem following lung transplantation